Sung‐Shuo Kao

<i>Helicobacter pylori</i> eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria

Ping‐I Hsu, Chao‐Yu Pan, John Y. Kao et al. · Helicobacter · 2018 · 93 citations

Randomized Controlled Trial Comparing 7-Day Triple, 10-Day Sequential, and 7-Day Concomitant Therapies for Helicobacter pylori Infection

Ping‐I Hsu, Deng‐Chyang Wu, Wen‐Chi Chen et al. · Antimicrobial Agents and Chemotherapy · 2014 · 76 citations · Full text

Ten‐Day Quadruple Therapy Comprising Proton‐Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin Achieves a High Eradication Rate for <i><scp>H</scp>elicobacter pylori</i> Infection after Failure of Sequential Therapy

Ping‐I Hsu, Wen‐Chi Chen, Feng‐Woei Tsay et al. · Helicobacter · 2013 · 44 citations

Equivalent Efficacies of Reverse Hybrid and Bismuth Quadruple Therapies in Eradication of Helicobacter pylori Infection in a Randomized Controlled Trial

Ping‐I Hsu, Feng‐Woei Tsay, David Y. Graham et al. · Clinical Gastroenterology and Hepatology · 2018 · 44 citations

Bismuth Quadruple Therapies, Health Sciences, Reverse Hybrid +6

Short‐term and long‐term impacts of <scp><i>Helicobacter pylori</i></scp> eradication with reverse hybrid therapy on the gut microbiota

Ping‐I Hsu, Chao‐Yu Pan, John Y. Kao et al. · Journal of Gastroenterology and Hepatology · 2019 · 44 citations · Full text